PTC Therapeutics, Inc. (NASDAQ:PTCT) Director Jerome B. Zeldis Sells 20,000 Shares of Stock

PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) Director Jerome B. Zeldis sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 22nd. The stock was sold at an average price of $38.24, for a total transaction of $764,800.00. Following the transaction, the director now owns 14,500 shares of the […]

Leave a Reply

Your email address will not be published.

Previous post Symbotic Inc. (NASDAQ:SYM) Major Shareholder Janet L. Cohen Sells 25,000 Shares
Next post Radian Group Inc. (NYSE:RDN) EVP Eric Ray Sells 65,305 Shares